Pandemic Darlings The pandemic economy, in original documents
Home Source documents Senate Commerce Committee Statement to Senate, No. 2886, Insulin Manufacturer Assistance Programs

Senate Commerce Committee Statement to Senate, No. 2886, Insulin Manufacturer Assistance Programs

Summary

Senate Commerce Committee statement to Senate on Senate Bill No. 2886, dated February 10, 2025, reporting the bill favorably with committee amendments. The bill requires pharmacies to provide information about insulin manufacturer assistance programs. As amended, a pharmacy practice site must display a notice on its website at all points of sale, drafted by the Department of Health, and give a pamphlet created by the department to anyone who asks. Insulin manufacturers with an assistance program may tell the department they want to be included. The effective date is twelve months from signing.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Cite this document

“Senate Commerce Committee Statement to Senate, No. 2886, Insulin Manufacturer Assistance Programs.” Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/2025-02-10-scm-s2886-s1-27da8e2920/, SHA-256 94dc7c18ffed0633e6a84d63c5febdd975b3765cc6a29e1d81575c59c8f2c981.

Full text

     SENATE COMMERCE COMMITTEE

                   STATEMENT TO

                 SENATE, No. 2886
                  with committee amendments



 STATE OF NEW JERSEY
                  DATED: FEBRUARY 10, 2025

    The Senate Commerce Committee reports favorably and with
committee amendments Senate Bill No. 2886.
   This bill requires pharmacies to provide certain information
regarding insulin manufacturer assistance programs.
   As amended, under this bill, a pharmacy practice site will be
required to display, in a conspicuous manner, a notice on its
website, concerning insulin manufacturer assistance programs at all
points of sale, the details of which are to be drafted by the
Department of Health. A pharmacy practice site is also required to
provide, upon the request of an individual, a pamphlet created by
the department concerning insulin manufacturer assistance
programs. Insulin manufacturers offering an assistance program
may inform the department of their intention to be included in the
notices and pamphlets. The effective date of the bill is twelve
months from the date it is signed into law.

COMMITTEE AMENDMENTS:
    The committee amended the bill to:
    (1) require a pharmacy to display, in a conspicuous manner,
information about insulin assistance programs on the website of the
pharmacy and have the Department of Health draft the information to
include on the website;
    (2) make the distribution of pamphlets on insulin assistance
programs by request of an individual to the pharmacy; and
    (3) alter the effective date to twelve months from the date it is
signed.

File and source

File
2025-02-10_SCM_S2886_S1.pdf
Size
8,490 bytes
SHA-256
94dc7c18ffed0633e6a84d63c5febdd975b3765cc6a29e1d81575c59c8f2c981
Our copy
2025-02-10_SCM_S2886_S1.pdf
Original
No public link identified.
Back to top